Alan Morgan has been named chief operating officer at Quanticate, reporting to chairman and chief executive officer David Underwood. Mr. Morgan will work across the global office network (US, UK, India, South Africa, and Poland) to build and expand the company’s customer service and clinical data services.

Mr. Morgan has extensive leadership experience within global CROs, with operational expertise and extensive knowledge across the pharmaceutical, biotechnology and medical device sectors. In his previous roles, he was responsible for global teams of more than 6000 employees in more than 72 countries. Prior to Quanticate, Mr. Morgan served in global leadership positions at various CRO’s including ICON, Covance, MDS and RPS.

“Quanticate has experienced strong growth in recent years and Alan’s oversight will enable us to continue to grow and provide the high quality service that Quanticate has built its name on over the years,” said Mr. Underwood. “Alan will be a real asset to both Quanticate and our customers as he will help to continue to optimize our processes whilst providing strategic direction for the future. As the Clinical Data Experts, Alan’s leadership over our operational teams will ensure the highest quality is delivered at all times to our customers and our leading position in the marketplace as a niche data-focused CRO is continually strengthened.”